home / stock / avdl / avdl news


AVDL News and Press, Avadel Pharmaceuticals plc From 04/02/24

Stock Information

Company Name: Avadel Pharmaceuticals plc
Stock Symbol: AVDL
Market: NASDAQ
Website: avadel.com

Menu

AVDL AVDL Quote AVDL Short AVDL News AVDL Articles AVDL Message Board
Get AVDL Alerts

News, Short Squeeze, Breakout and More Instantly...

AVDL - Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution

2024-04-02 03:40:17 ET Summary Avadel Pharmaceuticals reports strong Q4 2023 earnings for Lumryz, its once-nightly formulation of sodium oxybate for narcolepsy. Lumryz fills a significant gap in narcolepsy treatment by offering a more patient-friendly dosing schedule and improving...

AVDL - Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 23 rd Annual Needham Healthcar...

AVDL - When the Price of (AVDL) Talks, People Listen

2024-03-30 21:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

AVDL - Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang

2024-03-05 14:00:00 ET Summary Avadel's stock rose 51% post-buy recommendation, buoyed by Q4 earnings and a favorable royalty rate judgment versus Jazz Pharmaceuticals. Lumryz's market penetration and unique once-nightly dosing advantage are driving optimistic revenue forecasts an...

AVDL - Avadel Pharmaceuticals Issues Statement On Patent Litigation

DUBLIN, Ireland, March 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), today issued a statement in response to a jury ruling from the United States District Court for the District of Delaware (“Court”) in a patent suit brought by Jazz Pharmaceuticals Inc. reg...

AVDL - Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

-- Generated $19.5 million in fourth quarter and $28.0 million of full year 2023 net revenue from sales of LUMRYZ™ -- -- As of January 31 st , greater than 2,200 patients enrolled in RYZUP TM and more than 1,200 patients initiated therapy -- -- Pay...

AVDL - Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4

DUBLIN, Ireland, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 7:30 a.m. ET on Monday, March 4, 2024, to provide...

AVDL - How to Take Advantage of moves in (AVDL)

2024-02-18 11:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

AVDL - Learn to Evaluate (AVDL) using the Charts

2024-02-07 14:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

AVDL - Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Oppenheimer 34 th Annual Health...

Previous 10 Next 10